• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于长循环、低网状内皮系统清除和高肿瘤积累的混合荷电纳米粒子。

Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.

机构信息

MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.

出版信息

Adv Healthc Mater. 2014 Sep;3(9):1439-47. doi: 10.1002/adhm.201300617. Epub 2014 Feb 18.

DOI:10.1002/adhm.201300617
PMID:24550205
Abstract

Mixed-charge zwitterionic surface modification shows great potential as a simple strategy to fabricate nanoparticle (NP) surfaces that are nonfouling. Here, the in vivo fate of 16 nm mixed-charge gold nanoparticles (AuNPs) is investigated, coated with mixed quaternary ammonium and sulfonic groups. The results show that mixed-charge AuNPs have a much longer blood half-life (≈30.6 h) than do poly(ethylene glycol) (PEG, M¯w = 2000) -coated AuNPs (≈6.65 h) and they accumulate in the liver and spleen far less than do the PEGylated AuNPs. Using transmission electron microscopy, it is further confirmed that the mixed-charge AuNPs have much lower uptake and different existing states in liver Kupffer cells and spleen macrophages one month after injection compared with the PEGylated AuNPs. Moreover, these mixed-charge AuNPs do not cause appreciable toxicity at this tested dose to mice in a period of 1 month as evidenced by histological examinations. Importantly, the mixed-charge AuNPs have higher accumulation and slower clearance in tumors than do PEGylated AuNPs for times of 24-72 h. Results from this work show promise for effectively designing tumor-targeting NPs that can minimize reticuloendothelial system clearance and circulate for long periods by using a simple mixed-charge strategy.

摘要

混合电荷两性离子表面修饰作为一种简单的策略,具有很大的潜力来制备抗污的纳米颗粒(NP)表面。在这里,研究了带有混合季铵盐和磺酸基团的 16nm 混合电荷金纳米颗粒(AuNPs)的体内命运。结果表明,与聚乙二醇(PEG,M¯w = 2000)包覆的 AuNPs(≈6.65 h)相比,混合电荷 AuNPs 的血液半衰期(≈30.6 h)长得多,它们在肝脏和脾脏中的积累也远远少于 PEG 化的 AuNPs。使用透射电子显微镜进一步证实,与 PEG 化的 AuNPs 相比,注射一个月后,混合电荷 AuNPs 在肝枯否细胞和脾巨噬细胞中的摄取量更低,存在状态也不同。此外,在 1 个月的时间内,这些混合电荷 AuNPs 在小鼠中以测试剂量不会引起明显的毒性,这一点可以通过组织学检查得到证实。重要的是,与 PEG 化的 AuNPs 相比,混合电荷 AuNPs 在 24-72 h 的时间内具有更高的肿瘤积累和更缓慢的清除速度。这项工作的结果表明,通过使用简单的混合电荷策略,可以有效地设计出能够最小化网状内皮系统清除并长时间循环的肿瘤靶向 NP。

相似文献

1
Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.用于长循环、低网状内皮系统清除和高肿瘤积累的混合荷电纳米粒子。
Adv Healthc Mater. 2014 Sep;3(9):1439-47. doi: 10.1002/adhm.201300617. Epub 2014 Feb 18.
2
The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.配体组成对多齿聚乙二醇修饰金纳米粒子体内命运的影响。
Biomaterials. 2013 Nov;34(33):8370-81. doi: 10.1016/j.biomaterials.2013.07.059. Epub 2013 Aug 7.
3
Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior.通过控制纳米粒子的聚集行为来增强其在肿瘤中的保留和细胞摄取。
ACS Nano. 2013 Jul 23;7(7):6244-57. doi: 10.1021/nn402201w. Epub 2013 Jun 27.
4
Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells.金纳米颗粒的表面和尺寸效应对吞噬细胞和非吞噬细胞相互作用的影响。
Langmuir. 2013 Jul 23;29(29):9138-48. doi: 10.1021/la401556k. Epub 2013 Jul 11.
5
Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.表面涂层对金纳米粒子在大鼠体内生物分布的影响。
Eur J Pharm Biopharm. 2012 Jan;80(1):185-93. doi: 10.1016/j.ejpb.2011.09.005. Epub 2011 Sep 16.
6
Mixed charged zwitterionic self-assembled monolayers as a facile way to stabilize large gold nanoparticles.混合带电两性离子自组装单分子层作为稳定大尺寸金纳米粒子的简便方法。
Langmuir. 2011 May 3;27(9):5242-51. doi: 10.1021/la2002223. Epub 2011 Apr 8.
7
Size-dependent tissue kinetics of PEG-coated gold nanoparticles.PEG 修饰金纳米粒子的尺寸依赖性组织动力学
Toxicol Appl Pharmacol. 2010 May 15;245(1):116-23. doi: 10.1016/j.taap.2010.02.013. Epub 2010 Feb 26.
8
Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice.胶体金纳米颗粒作为小鼠X射线计算机断层扫描的血池造影剂。
Invest Radiol. 2007 Dec;42(12):797-806. doi: 10.1097/RLI.0b013e31811ecdcd.
9
Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells.柠檬酸稳定和聚乙二醇功能化金纳米粒子在人肝细胞和肾细胞中的细胞毒性、细胞内定位和胞吐作用。
Cell Biol Toxicol. 2016 Aug;32(4):305-21. doi: 10.1007/s10565-016-9336-y. Epub 2016 May 16.
10
A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.高剂量的聚乙二醇化金纳米粒子可降低加速血液清除现象的效果,并诱导白化小鼠脾脏 B 淋巴细胞。
Histochem Cell Biol. 2022 Jun;157(6):641-656. doi: 10.1007/s00418-022-02086-0. Epub 2022 Feb 14.

引用本文的文献

1
Antibody-Nanoparticle Conjugates in Therapy: Combining the Best of Two Worlds.抗体-纳米颗粒偶联物在治疗中的应用:融合两种优势。
Small. 2025 Apr;21(15):e2409635. doi: 10.1002/smll.202409635. Epub 2025 Mar 6.
2
Optimal size and PEG coating of gold nanoparticles for prolonged blood circulation: a statistical analysis of published data.用于延长血液循环时间的金纳米颗粒的最佳尺寸和聚乙二醇涂层:已发表数据的统计分析
Nanoscale Adv. 2025 Jan 13;7(3):722-727. doi: 10.1039/d4na00782d. eCollection 2025 Jan 28.
3
Enhancing in situ cancer vaccines using delivery technologies.
利用递送技术增强原位癌症疫苗。
Nat Rev Drug Discov. 2024 Aug;23(8):607-625. doi: 10.1038/s41573-024-00974-9. Epub 2024 Jul 1.
4
Beyond Lipids: Exploring Advances in Polymeric Gene Delivery in the Lipid Nanoparticles Era.超越脂质:探索脂质纳米颗粒时代中聚合物基因传递的新进展。
Adv Mater. 2024 Aug;36(31):e2404608. doi: 10.1002/adma.202404608. Epub 2024 Jun 19.
5
Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers.两性离子纳米级药物递送系统克服生物屏障的最新进展。
Asian J Pharm Sci. 2024 Feb;19(1):100883. doi: 10.1016/j.ajps.2023.100883. Epub 2023 Dec 29.
6
Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance.靶向癌症干细胞作为致癌和治疗抵抗的关键驱动因素。
Int J Mol Sci. 2023 Jan 16;24(2):1786. doi: 10.3390/ijms24021786.
7
Overview of Physicochemical Properties of Nanoparticles as Drug Carriers for Targeted Cancer Therapy.用于靶向癌症治疗的纳米颗粒作为药物载体的物理化学性质概述
J Funct Biomater. 2022 Oct 20;13(4):196. doi: 10.3390/jfb13040196.
8
Metal-Polymer Nanoconjugates Application in Cancer Imaging and Therapy.金属-聚合物纳米共轭物在癌症成像与治疗中的应用。
Nanomaterials (Basel). 2022 Sep 13;12(18):3166. doi: 10.3390/nano12183166.
9
Advances in Hybrid Vesicular-based Drug Delivery Systems: Improved Biocompatibility, Targeting, Therapeutic Efficacy and Pharmacokinetics of Anticancer Drugs.基于混合囊泡的药物传递系统的进展:提高抗癌药物的生物相容性、靶向性、治疗效果和药代动力学。
Curr Drug Metab. 2022;23(9):757-780. doi: 10.2174/1389200223666220627110049.
10
Micropatterned immobilization of membrane-mimicking polymer and peptides for regulation of cell behaviors .用于调节细胞行为的膜模拟聚合物和肽的微图案固定化
RSC Adv. 2018 Jun 6;8(37):20836-20850. doi: 10.1039/c8ra02607f. eCollection 2018 Jun 5.